BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6689638)

  • 1. A method for quantitating antifibrillatory effects of drugs after coronary reperfusion in dogs: improved outcome with bretylium.
    Wenger TL; Lederman S; Starmer CF; Brown T; Strauss HC
    Circulation; 1984 Jan; 69(1):142-8. PubMed ID: 6689638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of ventricular fibrillation by bretylium in a conscious canine model of sudden coronary death.
    Holland K; Patterson E; Lucchesi BR
    Am Heart J; 1983 May; 105(5):711-7. PubMed ID: 6846113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental and clinical pharmacology of bretylium tosylate in acute myocardial infarction: a 15-year journey.
    Puddu PE; Jouve R; Saadjian A; Torresani J
    J Pharmacol; 1986; 17(3):223-43. PubMed ID: 3795968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of chronic canine ventricular tachyarrhythmias with bretylium tosylate.
    Patterson E; Gibson JK
    Circulation; 1981 Nov; 64(5):1045-50. PubMed ID: 7285294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrophysiologic effects of bretylium tosylate on the canine heart during coronary artery occlusion and reperfusion.
    Gibson JK; Stewart JR; Li YP; Lucchesi BR
    J Cardiovasc Pharmacol; 1983; 5(4):517-24. PubMed ID: 6193345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bretylium tosylate in patients with acute myocardial infarction.
    Torresani J
    Am J Cardiol; 1984 Jul; 54(2):20A-25A. PubMed ID: 6464996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amiodarone versus bretylium for suppression of reperfusion arrhythmias in dogs.
    Rosalion A; Snow NJ; Horrigan TP; Noon DL; Mostow ND
    Ann Thorac Surg; 1991 Jan; 51(1):81-5. PubMed ID: 1985582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of bretylium tosylate as prophylaxis and treatment in hypothermic ventricular fibrillation in the canine model.
    Murphy K; Nowak RM; Tomlanovich MC
    Ann Emerg Med; 1986 Oct; 15(10):1160-6. PubMed ID: 3752646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ischemia-induced conduction delay and ventricular arrhythmias: comparative electropharmacology of bethanidine sulfate and bretylium tosylate.
    Kabell G
    J Cardiovasc Pharmacol; 1989 Mar; 13(3):471-82. PubMed ID: 2471895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of bretylium and clofilium on dispersion of refractoriness and vulnerability to ventricular fibrillation in the ischemic feline heart.
    Kowey PR; Friehling TD; O'Connor KM; Wetstein L; Kelliher GJ
    Am Heart J; 1985 Aug; 110(2):363-70. PubMed ID: 4025111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrophysiologic effects of bretylium on canine ventricular muscle during acute ischemia and reperfusion.
    Fujimoto T; Hamamoto H; Peter T; McCullen A; McCullen A; Melvin N; Mandel WJ
    Am Heart J; 1983 Jun; 105(6):966-72. PubMed ID: 6858845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bretylium tosylate in the treatment and prevention of ventricular arrhythmia: a new look at an old drug].
    DÅ‚uzniewski M
    Pol Tyg Lek; 1988 Oct; 43(44):1415-8. PubMed ID: 3075282
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of bretylium tosylate on the in vivo fibrillating canine ventricle.
    Breznock EM; Kagan K; Hibser NK
    Am J Vet Res; 1977 Jan; 38(1):89-94. PubMed ID: 835872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of ventricular dysrhythmias in the prehospital and emergency department setting.
    Mayer NM
    Am J Cardiol; 1984 Jul; 54(2):34A-36A. PubMed ID: 6464998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ventricular fibrillation following canine coronary artery reperfusion: different outcomes with pentobarbital and alpha-chloralose.
    Wenger TL; Harrell FE; Brown KK; Lederman S; Strauss HC
    Can J Physiol Pharmacol; 1984 Feb; 62(2):224-8. PubMed ID: 6713289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of ventricular fibrillation during hypothermia with bretylium tosylate.
    Buckley JJ; Bosch OK; Bacaner MB
    Anesth Analg; 1971; 50(4):587-93. PubMed ID: 5105113
    [No Abstract]   [Full Text] [Related]  

  • 17. Failure of bretylium to suppress inducible ventricular tachycardia.
    Greene HL; Werner JA; Gross BW; Sears GK
    Am Heart J; 1983 May; 105(5):717-21. PubMed ID: 6846114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antifibrillatory action of bretylium: role of the sympathetic nervous system.
    Kopia GA; Lucchesi BR
    Pharmacology; 1987; 34(1):37-47. PubMed ID: 3575413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The antiarrhythmic and antifibrillatory actions of bretylium and its o-iodobenzyl trimethylammonium analog, UM-360.
    Kniffen FJ; Lomas TE; Counsell RE; Lucchesi BR
    J Pharmacol Exp Ther; 1975 Jan; 192(1):120-8. PubMed ID: 1123718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vagally-mediated atrial fibrillation in dogs: conversion with bretylium tosylate.
    Goldberger AL; Pavelec RS
    Int J Cardiol; 1986 Oct; 13(1):47-55. PubMed ID: 3771001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.